Patient reactions prompt amoxicillin powder recall
Manufacturer Wockhardt UK has recalled batches of its amoxicillin powder following reports of adverse reactions to injections
Manufacturer Wockhardt UK has recalled batches of its amoxicillin powder following reports of adverse reactions to injections.
The MHRA issued an alert yesterday (July 22) for the recall of three batches of 500mg vials of the antibiotic for infusion after it received a "small number" of reports of adults and children suffering reactions on the site of their injection.
The recall is part of an ongoing investigation with Wockhardt's contract manufacturer in Italy. According to the MHRA, there was no evidence to suggest the batches were defective.
The medicines watchdog advised health professionals to quarantine all remaining stock and return it to the original supplier for credit.
For stock enquiries, contact Wockhardt's customer service department on 01978 669215 or [email protected]. For medical enquiries, contact its medical information department on 01978 661261 or [email protected]
The affected batches are:
Batch number |
Expiry date |
Pack size |
First distributed |
1WA4002 |
January 31, 2017 |
10 x 500mg |
April 14, 2014 |
1WA4003 |
January 31, 2017 |
10 x 500mg |
February 28, 2014 |
1WA4004 |
January 31, 2017 |
10 x 500mg |
April 15, 2014 |
|
Related stories
|
|
We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information
|